Clinical Trial Update: Exploratory Blood-Based Biomarkers in TACE-Treated Hepatocellular Carcinoma

View source ↗

Summary

An ongoing clinical trial in Belgrade is investigating blood-based biomarkers in hepatocellular carcinoma patients treated with transarterial chemoembolization …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma
• Liver Neoplasms

Snippet

Sponsor: University of Belgrade | Conditions: Hepatocellular Carcinoma (HCC), Liver Neoplasms | Status: RECRUITING